Table of Contents
EXECUTIVE SUMMARY
- Snapshot: Strategic Espicom Analysis
- Snapshot: Key Data Projections
MACROENVIRONMENT
- POLITICAL
- ECONOMIC
- LEGAL
- Background to Pharmaceutical Patents
- Mashelkar Committee Report, December 2006
- The Patents (Amendments) Bill, 2005
- The Patents (Amendment) Rules 2006
- Previous Patents Act Amendments and Exclusive Marketing Rights
- DEMOGRAPHIC
- Population
- Demographic Indicators
EPIDEMIOLOGY
- DISEASE BURDEN
- Leading Causes of Mortality
- DISEASE PREVALENCE
- Communicable Diseases
- Non-Communicable Diseases
- Public Health Programmes
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS
- ORGANISATION
- Department of Health and Family Welfare
- The Department of AYUSH
- Health Insurance
- EXPENDITURE
- Projections
- Latest Figures
- INFRASTRUCTURE
- Hospital Infrastructure
- Private Hospitals and Clinics
- Ambulatory Infrastructure
- WORKFORCE
- Projections
- Latest Figures
REGULATORY AFFAIRS
- NATIONAL AUTHORITY
- REGULATORY DEVELOPMENTS
- National Pharmaceuticals Policy 2006
- MARKETING REGISTRATION
- DGCI set to co-ordinate drug approvals
- PROMOTION
PRICING
- Drugs (Prices Control) Amendment Order and Second Amendment Order, 2006
- Drug Price Control Review Committee
DISTRIBUTION CHANNELS
- Medical Stores Organisation
- Pharmacy Chains
MARKET ANALYSIS
- SIZE
- Projections
- Current Size
- Current Structure
- PRODUCT DEVELOPMENT
- MANUFACTURING
- BCG Vaccine Laboratory, Chennai
- TRADE
- Exports
- Imports
- Balance of Trade
COMPETITION
- TRADE ASSOCIATIONS
- TRADE FAIRS
- India Chem 2010
- IndiaMART India International Pharma Show
- Bangalore Bio
- Pharma World EXPO
- COMPANY INTELLIGENCE
- Foreign Private Producers
- Actavis
- GlaxoSmithKline
- Pfizer India
- sanofi-aventis
- Local Private Producers
- Alembic Ltd
- Aurobindo Pharma
- Blue Cross Laboratories Ltd
- Cipla Ltd
- Claris Lifesciences
- Dr Reddy' s Laboratories Ltd
- Glenmark Pharmaceuticals
- Jubilant Organosys
- Lupin Limited
- Matrix Laboratories
- Natco Pharma
- Orchid Chemicals & Pharmaceuticals Ltd
- Piramal Healthcare
- Strides Arcolab
- Sun Pharma
- Torrent Pharmaceuticals
- Wockhardt Ltd
- Zydus Cadila
- COMPETITIVE STRATEGIES
- Recent Acquisitions
- Agreements
BIOLOGICS & BIOSIMILARS
- COMPETITION
- Company Intelligence
- Biocon
- Claris Lifesciences
- Dr Reddy' s
- Glenmark Pharmaceuticals
- Ranbaxy
- Wockhardt
- Zydus Cadila
CONCLUSIONS: OPPORTUNITIES & CHALLENGES
- Strategic Espicom Analysis
- MACROENVIRONMENT
- EPIDEMIOLOGY
- HEALTHCARE
- REGULATORY AFFAIRS
- PRICING & REIMBURSEMENT
- DISTRIBUTION CHANNELS
- MARKET
- COMPETITION
- OTC PHARMACEUTICALS
- GENERICS
- BIOLOGICS & BIOSIMILARS
- Radar & SWOT Analysis
DIRECTORY
- Government Organisations
- Trade Associations
List of Tables
- Espicom Analysis of the Pharmaceutical Market, 2010
- Key Data Projections, 2010-2015
- Political Landscape, 2010
- Regional Comparison of Projected Economies, 2015
- Projected Economy, 2010-2015
- Population by States and Territories, 2007 (000s)
- Projected Demographics, 2010-2015
- Regional Comparison of Projected Demographics, 2015
- Summary of Demographic Data
- Demographic Indicators, 2000-06
- Reported Incidence of Vaccine Preventable Diseases, 2006
- Reported Malaria Incidence & Deaths, 2006
- Reported Kala-azar Cases & Deaths, 2006
- Suspected Japanese Encephalitis Cases & Deaths, 2006
- Regional Comparison of Projected Health Expenditure, 2015
- Projected Health Expenditure, 2010-2015
- Healthcare Expenditure, 2010
- Hospitals & Beds, 2002
- Hospital Bed Projections, 2010-2015
- Beds in Selected Hospitals, 2007
- AIIMS Hospital Activity, 2005/06
- Regional Comparison of Projected Physicians, 2015
- Projected Physicians, 2010-2015
- Doctors Registered with State Medical Councils, 2005-2007
- Regional Comparison of Projected Pharmaceutical Markets, 2015
- Projected Pharmaceutical Market, 2010-2015
- Pharmaceutical Market, 2010
- Pharmaceutical Exports by Category, 2004-2008 (US$000s)
- Leading Destinations of Pharmaceuticals, 2008 (US$000s)
- Pharmaceutical Imports by Category, 2004-2008 (US$000s)
- Imports of Raw Materials by Country/Region, 2008 (US$000s)
- Imports of Antisera & Vaccines by Country/Region, 2008 (US$000s)
- Imports of Semi-finished Medicaments by Country/Region, 2008 (US$000s)
- Imports of Medicaments by Country/Region, 2008 (US$000s)
- Balance of Pharmaceutical Trade, 2004-2008 (US$000s)
- Alembic: Manufacturing Facilities
- Alembic: FDA ANDA Approvals, 2009
- Alembic: Financial Results 2005-2009
- Aurobindo Pharma: Manufacturing Facilities
- Aurobindo Pharma: ANDA Approvals, 2007-2009
- Cephazone Pharma: FDA ANDA Approval, 2007
- Aurobindo Pharma: Financial Results, 2005-2009
- Cipla: Manufacturing Facilities
- Cipla: FDA ANDA Approvals, 2007-2009
- Cipla: Tentative FDA ANDA Approvals
- Cipla: Tentative FDA NDA Approvals
- Cipla: Financial Results, 2005-2009
- Claris Lifesciences: FDA ANDA Approvals, 2008
- Dr Reddy' s: Manufacturing Facilities
- Dr Reddy' s: FDA ANDA Approvals, 2007-2009
- Dr Reddy' s: Financial Summary, 2005-2009
- Glenmark: Manufacturing Facilities
- Glenmark: FDA ANDA Approvals, 2007-2009
- Glenmark: Financial Results, 2005-2009
- Jubilant Organosys: FDA ANDA Approvals, 2004-2009
- Jubilant Organosys: Financial Results, 2005-2009
- Lupin: Manufacturing Facilities
- Lupin: FDA ANDA Approvals 2007-2009
- Lupin: Tentative FDA Approvals
- Lupin: Financial Results, 2005-2009
- Matrix: Manufacturing Facilities
- Matrix: FDA ANDA Approvals, 2008-2009
- Matrix: Tentative ANDA Approvals
- Matrix: Financial Results, 2004-2008
- Natco Pharma Financial Results, 2003-2007
- Orchid: Manufacturing Facilities
- Orchid' s Top-10 Brands
- Orchid: FDA ANDA Approvals, 2007-2009
- Orchid: Financial Results, 2005-2009
- Piramal Healthcare: Manufacturing Facilities
- Piramal Healthcare: Financial Results, 2005-2009
- Ranbaxy: Manufacturing Facilities
- Ranbaxy Laboratories: FDA ANDA Approvals, 2007-2009
- Ohm Laboratories: FDA ANDA Approvals, 2006-2008
- Ranbaxy: Financial Results, 2004-2008
- Akorn Strides: FDA ANDA Approvals, 2007-2009
- Sagent Strides: FDA ANDA Approvals
- Strides: Financial Results, 2005-2008
- Sun Pharma: Manufacturing Facilities
- Sun Pharma: FDA ANDA Approvals, 2007-2009
- Caraco Pharmaceutical: ANDA Approvals, 2007-2008
- Sun Pharma: Financial Results, 2005-2009
- Torrent Pharma: FDA ANDA Approvals, 2007-2009
- Torrent Pharma: Financial Results, 2004-2008
- Wockhardt Manufacturing Facilities
- Wockhardt: FDA ANDA Approvals, 2007-2009
- Wockhardt: Financial Results, 2004-2008
- Zydus Cadila: Manufacturing Facilities
- Zydus: ANDA Approvals, 2007-2009
- Zydus Cadila: Financial Results, 2004-2008
- Biocon: Financial Results, 2005-2009
- Espicom Analysis of the Pharmaceutical Market, 2010
- SWOT Analysis of the Pharmaceutical Market, 2010
List of Charts
- Population by Age Group, 2006 (%)
- Medically Certified Deaths by Cause, 2000
- Health Expenditure by Source, 2001/02 (%)
- Pharmaceutical Exports, 1998-2008 (US$ Millions)
- Change in Pharmaceutical Exports, 2004-2008 (%)
- Pharmaceutical Imports, 1998-2008 (US$ Millions)
- Change in Pharmaceutical Imports, 2004-2008 (%)
- Pharmaceutical Imports by Country/Region, 2008 (%)
- Pharmaceutical Balance of Trade, 1998-2008 (US$ Billions)
- Radar Graph of the Pharmaceutical Market, 2010
|
Related Report
|
View Cart
